| Literature DB >> 28956018 |
Ken Motohashi1,2.
Abstract
Simple and low-cost recombinant enzyme-free seamless DNA cloning methods have recently become available. In vivo Escherichia coli cloning (iVEC) can directly transform a mixture of insert and vector DNA fragments into E. coli, which are ligated by endogenous homologous recombination activity in the cells. Seamless ligation cloning extract (SLiCE) cloning uses the endogenous recombination activity of E. coli cellular extracts in vitro to ligate insert and vector DNA fragments. An evaluation of the efficiency and utility of these methods is important in deciding the adoption of a seamless cloning method as a useful tool. In this study, both seamless cloning methods incorporated inserting DNA fragments into linearized DNA vectors through short (15-39 bp) end homology regions. However, colony formation was 30-60-fold higher with SLiCE cloning in end homology regions between 15 and 29 bp than with the iVEC method using DH5α competent cells. E. coli AQ3625 strains, which harbor a sbcA gene mutation that activates the RecE homologous recombination pathway, can be used to efficiently ligate insert and vector DNA fragments with short-end homology regions in vivo. Using AQ3625 competent cells in the iVEC method improved the rate of colony formation, but the efficiency and accuracy of SLiCE cloning were still higher. In addition, the efficiency of seamless cloning methods depends on the intrinsic competency of E. coli cells. The competency of chemically competent AQ3625 cells was lower than that of competent DH5α cells, in all cases of chemically competent cell preparations using the three different methods. Moreover, SLiCE cloning permits the use of both homemade and commercially available competent cells because it can use general E. coli recA- strains such as DH5α as host cells for transformation. Therefore, between the two methods, SLiCE cloning provides both higher efficiency and better utility than the iVEC method for seamless DNA plasmid engineering.Entities:
Keywords: CFU, colony-forming units; G6PDH1, glucose-6-phosphate dehydrogenase 1; Homologous recombination; PCR, polymerase chain reaction; Prx IIE, type II peroxiredoxin E; SLiCE; SLiCE, seamless ligation cloning extract; Seamless DNA cloning; TSS, transformation and storage solution.; iVEC, in vivo Escherichia coli cloning; in vivo Escherichia coli cloning
Year: 2017 PMID: 28956018 PMCID: PMC5614619 DOI: 10.1016/j.bbrep.2017.01.010
Source DB: PubMed Journal: Biochem Biophys Rep ISSN: 2405-5808
Fig. 1Workflow of iVEC-DH5α and SLiCE cloning with purified PCR fragments. Insert DNA fragments were PCR-amplified, purified, and mixed with linearized vector DNA. The mixture of insert and vector DNAs was directly transformed into DH5α cells in the iVEC method (in vivo ligation). The mixture ligated using SLiCE (in vitro ligation) was transformed into DH5α cells in the SLiCE method. Chemically competent DH5α cells were prepared by the modified TSS method (DH5α, 1.5×106 CFU/μg pUC19 DNA)).
Fig. 2Cloning efficiency of iVEC-DH5α and SLiCE using purified PCR fragments. The number of colonies formed (i.e., colony formation rate) with purified PCR fragments of variable end homology region lengths (15,19,29, or 39 bp) using the iVEC-DH5α method [17], [18] or the SLiCE method [15], [23]. Number of colonies indicates the number of colonies that formed when 3 ng of vector DNA was transformed. Purified insert DNA fragments of PrxIIE (4 ng) and linearized pET23a vector (10 ng) were mixed in 10 μL. iVEC was directly transformed to DH5α competent cells using 3 μL in 10 μL. The SLiCE sample was reacted in a total volume of 10 μL, and then 3 μL of the 10 μL was used for transformation to DH5α. Each value for the number of colonies is the mean±standard deviation of three independent experiments. DH5α chemically competent cells for both the iVEC-DH5α method and the SLiCE method were prepared with a competency of 1.5×106 (CFU/μg pUC19 DNA) by the modified TSS method.
Cloning efficiency and cloning accuracy of iVEC-DH5α and SLiCE cloning methods using purified PCR fragments (PrxIIE).
| Method | Homology length (bp) | Cloning efficiency | Cloning accuracy |
|---|---|---|---|
| iVEC (DH5α) | 15 | 6/11 (54.5%) | 4/6 (66.7%) |
| 19 | 2/7 (28.6%) | 2/2 (100%) | |
| 29 | 7/11 (63.6%) | 6/7 (85.7%) | |
| 39 | 10/14 (71.4%) | 10/10 (100%) | |
| SLiCE | 15 | 10/16 (62.5%) | 9/10 (90.0%) |
| 19 | 15/16 (93.8%) | 12/15 (80.0%) | |
| 29 | 15/16 (93.8%) | 13/15 (86.7%) | |
| 39 | 11/16 (68.8%) | 10/11 (90.9%) |
Insert DNA fragments of the PrxIIE gene (0.5 kbp) and linearized pET23a vector DNA were amplified by PCR, and purified by agarose gel electrophoresis and a Gel/PCR Extraction Kit (FastGene). Purified insert DNA fragments (4 ng) and linearized pET23a vector DNA (10 ng) were used at an insert:vector molar ratio of 3:1. Part (3 μL) of the total 10 μL solution was used to transform DH5α competent cells (1.5×106 CFU/μg pUC19 DNA) prepared by the modified TSS method [30].
Cloning efficiency is defined as the fraction of total colonies in which a PCR product of the correct expected size was amplified by colony PCR amplification.
Cloning accuracy is defined as the fraction of clones correctly confirmed by DNA sequencing among colony-PCR positive clones.
Fig. 3Workflow of iVEC-AQ3625 and SLiCE cloning with unpurified DNA fragments. Insert DNA fragments were PCR-amplified and mixed with linearized vector DNA, without purification. The mixture of insert and vector DNAs was directly transformed into AQ3625 cells in the iVEC method (in vivo ligation). The mixture ligated using SLiCE (in vitro ligation) was transformed into DH5α cells in the SLiCE method. Chemically competent DH5α (1.5×106 CFU/μg pUC19 DNA) and AQ3625 (0.78×106 CFU/μg pUC19 DNA) cells were prepared by the modified TSS method [30]. Short (19 bp) end homology regions between insert and vector DNAs were used.
Colony formation rate, cloning efficiency, and cloning accuracy of iVEC-AQ3625 and SLiCE cloning methods using unpurified PCR fragments (PrxIIE and G6PDH1).
| Method | Insert DNA | Number ofcolonies | Cloning efficiency | Cloning accuracy |
|---|---|---|---|---|
| iVEC(AQ3625) | 58±8 | 3/16 (18.8%) | 1/3 (33.3%) | |
| 43±23 | 0/16 (0.00%) | – | ||
| SLiCE | 27±11 | 15/16 (93.8%) | 13/15 (86.7%) | |
| 25±11 | 10/16 (62.5%) | 9/10 (90.0%) |
Insert DNA fragments of PrxIIE (0.5 kbp) and G6PDH1 (1.6 kbp) genes, which have short (19 bp) end homology regions, were amplified by PCR, and treated by DpnI. Unpurified insert DNA fragments of PrxIIE (21 ng) or G6PDH1 (67 ng), and linearized pET23a vector DNA (purified, 50 ng) were used at an insert:vector molar ratio of 3:1. Part (3 μL) of the total 10 μL solution was used to transform chemically competent cells prepared by the modified TSS method [30]: AQ3625 (0.78×106 CFU/μg pUC19 DNA) or DH5α (1.5×106 CFU/μg pUC19 DNA).
Number of colonies indicates the number of colonies that formed when 15 ng of vector DNA was transformed. Each value for the number of colonies is the mean±standard deviation of three independent experiments.
Cloning efficiency is defined as the fraction of total colonies in which a PCR product of the correct expected size was amplified by colony PCR amplification.
Cloning accuracy is defined as the fraction of clones correctly confirmed by DNA sequencing among colony-PCR positive clones.
Competency of E. coli DH5α and AQ3625 chemically competent cells.
| methods | strain | competency (CFU /μg pUC19 DNA) |
|---|---|---|
| Modified TSS method | DH5α | 1.5×106 |
| AQ3625 | 7.8×105 | |
| Inoue's method | DH5α | 1.8×107 |
| AQ3625 | 0.5×105 | |
| Calcium chloride method | DH5α | 1.2×105 |
| AQ3625 | 0.1×105 |
DH5α and AQ3625 were harvested at OD600=0.55 and 0.41, respectively.
DH5α and AQ3625 were harvested at OD600=0.16 and 0.27, respectively.
DH5α and AQ3625 were harvested at OD600=0.46 and 0.56, respectively.